Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study

J Am Acad Dermatol. 2022 Nov;87(5):1186-1189. doi: 10.1016/j.jaad.2022.03.004. Epub 2022 Mar 7.

Affiliations

¹ Dermatology Digital Center, Department of Medical and Surgical Dermatology, Seville, Spain. Electronic address: david.moreno.ramirez.sspa@juntadeandalucia.es.
² Dermatology Digital Center, Department of Medical and Surgical Dermatology, Seville, Spain.
³ Communication and Technology Department, Hospital Universitario Virgen Macarena, Seville, Spain.

No abstract available

Keywords: acne; general dermatology; isotretinoin; teledermatology; telemedicine.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Acne Vulgaris* / chemically induced
Acne Vulgaris* / drug therapy
COVID-19*
Dermatologic Agents* / adverse effects
Feasibility Studies
Humans
Isotretinoin / adverse effects
Pandemics
Prospective Studies
Telemedicine*

Substances

Dermatologic Agents
Isotretinoin